Theyre conversations worth having with your AF team, not reasons to stop Mounjaro
If GLP-1 weight loss injections like tirzepatide (Zepbound, Mounjaro) are already doing their job, switching isn't automatically an upgrade
nausea occurs in up to 31% of tirzepatide initiators Who should not switch / Patients with personal or family history of medullary thyroid carcinoma or MEN2 syndrome (contraindication shared by both drugs) Why Patients Switch from Semaglutide to Tirzepatide Switching GLP-1 therapies is not a fringe scenario
The inclusion of high-dose NAC in post-viral recovery protocols is supported by robust, emerging clinical data
In the end, the goal is universal: to ensure that every individual has the opportunity to live a healthier, happier life, free from the financial and physical burdens of untreated or unmanaged conditions
Clinical trials generally identify the most dangerous side effects of drugs, but they can fail to find what symptoms patients are most concerned about, says Lyle H